返回 Agenda
Session Chair(s)
Kerstin Dahlström, MPHARM, MS
Director Transparency and Outsourcing
H. Lundbeck A/S, Denmark
Speaker(s)
De-Identification of Patient Data in Rare Disease Clinical Studies – Special Considerations
Adel Salem
Novo Nordisk, Denmark
Senior Programmer
The Impact of Clinical Trial Data Disclosure on Trial-related Documents: Redaction Requirements and Future Document Structure
Tracy Farrow
PPD, United Kingdom
Senior Director Medical Writing
How We Deliver It All Together – Reflections on Medical Writers’ Collaboration with Other Skill Groups
Kerstin Dahlström, MPHARM, MS
H. Lundbeck A/S, Denmark
Director Transparency and Outsourcing